On Thursday, April 12 an FDA advisory panel will discuss whether or not to recommend that the FDA approve Merck & Co’s... Read more »
On April 12th, a Food and Drug Administration, FDA, advisory panel of experts rejected Merck’s drug, Arcoxia, in a 20-1 vote. It is a... Read more »
On November 13th, the Associated Press released an article showing mixed reviews of Arcoxia, the cox-2 inhibitor drug that Merck is hoping... Read more »
Is it truly possible Tylenol (a.k.a. acetominophen) causes asthma? The evidence seems to be pointing in that direction. A stunning... Read more »
While FDA is trying to figure out ways to slow down the rate of acetaminophen-associated overdoses, McNeil - the maker of Tylenol brands -... Read more »
An advisory panel to the U.S. Food and Drug Administration has found mixed results about the safety of the new COX-2 inhibitor Arcoxia. In a recent... Read more »
This is a study to assess different doses of Arcoxia/MK-0663 in the treatment of patients with rheumatoid arthritis. This national study is currently... Read more »
A new study on the COX-2 inhibitor Arcoxia is intensifying worries about the drug's safety. Though researchers found that the new drug had similar... Read more »
The U.S. Food and Drug Administration (FDA) has rejected drugmaker Merck's request to sell the COX-2 inhibitor Arcoxia in the United States. Arcoxia... Read more »
According to new research, acetaminophen (more commonly known as Tylenol) may relieve not only physical aches and pains but also the pain of hurt... Read more »